Indaptus Therapeutics Inc (INDP) posted a 25.54% change over the last five days signaling a new trend

Indaptus Therapeutics Inc (NASDAQ: INDP) kicked off on Friday, up 6.40% from the previous trading day, before settling in for the closing price of $3.28. Over the past 52 weeks, INDP has traded in a range of $2.22-$58.24.

During the last 5-year period, the sales growth of Healthcare Sector giant was 57.27%. While this was happening, its average annual earnings per share was recorded 50.60%. With a float of $1.00 million, this company’s outstanding shares have now reached $1.11 million.

Indaptus Therapeutics Inc (INDP) Breakdown of a Key Holders of the stock

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Indaptus Therapeutics Inc is 9.46%, while institutional ownership is 4.58%.

Indaptus Therapeutics Inc (INDP) Recent Fiscal highlights

In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -8.96 earnings per share (EPS), higher than consensus estimate (set at -13.16) by 4.2. Wall Street market experts anticipate that the next fiscal year will bring earnings of -4.32 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 50.60% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 34.36% during the next five years compared to 57.27% growth over the previous five years of trading.

Indaptus Therapeutics Inc (NASDAQ: INDP) Trading Performance Indicators

Take a look at Indaptus Therapeutics Inc’s (INDP) current performance indicators. Last quarter, stock had a quick ratio of 0.75.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -37.56, a number that is poised to hit -4.17 in the next quarter and is forecasted to reach -13.56 in one year’s time.

Technical Analysis of Indaptus Therapeutics Inc (INDP)

Looking closely at Indaptus Therapeutics Inc (NASDAQ: INDP), its last 5-days average volume was 3.2 million, which is a jump from its year-to-date volume of 0.2 million. As of the previous 9 days, the stock’s Stochastic %D was 60.71%.

During the past 100 days, Indaptus Therapeutics Inc’s (INDP) raw stochastic average was set at 7.18%, which indicates a significant decrease from 20.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.71 in the past 14 days, which was lower than the 1.08 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $6.29, while its 200-day Moving Average is $14.88. However, in the short run, Indaptus Therapeutics Inc’s stock first resistance to watch stands at $6.96. Second resistance stands at $10.42. The third major resistance level sits at $12.28.

Indaptus Therapeutics Inc (NASDAQ: INDP) Key Stats

The company with the Market Capitalisation of 3.86 million has total of 1,107K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -15,020 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -5,230 K.